Market Outlook

By 2035, the U.S. Minimally Invasive Orthopedic Devices Market is expected to reach approximately USD 32.66 billion, expanding at a CAGR of 8.20% during the forecast period 2026-2035. The market was valued at USD 14.85 billion in 2025, following historical expansion from USD 10.83 billion in 2021 to USD 13.72 billion in 2024. Values in this report are expressed in USD billions. The estimate covers devices, implants, instruments, visualization systems and enabling technologies specifically used in arthroscopic, percutaneous, endoscopic, robotic-assisted, navigation-guided and other small-incision orthopedic procedures. Conventional open orthopedic devices and general-purpose hospital imaging systems are excluded unless they are directly integrated into a minimally invasive orthopedic workflow.

The U.S. market is entering a higher-value phase in which minimally invasive orthopedic surgery is no longer limited to arthroscopy or selected spine procedures. The addressable ecosystem now includes robotic-assisted joint reconstruction, endoscopic spine surgery, percutaneous fixation, patient-specific instrumentation, disposable soft-tissue repair systems, advanced suture anchors, radiofrequency tissue management, biologic delivery instruments, 3D surgical planning and digitally connected recovery pathways. These technologies are gaining adoption because they can support smaller incisions, lower soft-tissue disruption, reduced blood loss, shorter hospitalization, faster rehabilitation and a larger proportion of procedures performed in ambulatory settings.

Demand is supported by a durable clinical base. Diagnosed arthritis affects a substantial share of U.S. adults and rises sharply with age, while obesity, sports participation, degenerative spine disease and fragility fractures expand the pool of patients requiring orthopedic intervention. The U.S. population age 65 and older reached more than 61 million in 2024, and all baby boomers will be at least 65 by 2030. This demographic shift is commercially important because older adults account for a disproportionate share of hip, knee, shoulder, spine and fracture procedures. At the same time, younger and middle-aged patients increasingly expect rapid return to work and activity, supporting demand for tissue-preserving techniques and outpatient rehabilitation.

Historical growth from 2021 through 2024 reflected recovery in elective orthopedic volumes, expansion of hospital outpatient departments and ambulatory surgery centers, and accelerating investment in robotic and navigation platforms. In 2025, growth was reinforced by broader use of robotic-assisted knee and hip procedures, increased adoption of minimally invasive spine systems, higher shoulder arthroscopy and sports medicine volumes, and replacement demand for arthroscopy towers, powered instruments and implant delivery systems. Through 2035, market value will expand faster than procedure volume because technology mix is shifting toward premium enabling systems, higher-value disposable instruments, advanced implants and software-linked procedural platforms.

 

Introduction

According to the U.S. Minimally Invasive Orthopedic Devices Market Report, the market is defined by the intersection of musculoskeletal disease burden, surgeon preference, hospital capital planning, payer policy and site-of-care migration. Orthopedic surgery in the United States is increasingly evaluated through episode economics rather than the device invoice alone. Hospitals and ambulatory surgery centers are assessing whether a technology can reduce operating-room time, lower sterilization burden, standardize technique, shorten length of stay, decrease post-acute utilization and improve patient-reported outcomes. Devices that demonstrate value across these dimensions can command premium pricing even in categories exposed to purchasing-group pressure.

The market is structurally diverse. Arthroscopy and sports medicine generate recurring revenue through anchors, sutures, cannulas, shavers, burs, ablation probes, fluid management sets and visualization accessories. Minimally invasive spine procedures use percutaneous pedicle screw systems, expandable interbody cages, tubular retractors, endoscopes, navigation instruments and biologic delivery products. Small-incision joint reconstruction increasingly combines implants with robotic arms, handheld robotics, optical tracking, 3D planning and patient-specific workflows. Trauma and extremity procedures use percutaneous plating, intramedullary fixation, compression systems and low-profile implants designed to preserve soft tissue. The mix of capital equipment and procedure-specific consumables provides a balanced revenue model with both installed-base and recurring components.

The U.S. care-delivery infrastructure is large enough to support sustained adoption. The country has more than 6,000 hospitals, over 900,000 staffed beds and a rapidly expanding ambulatory surgery network. Orthopedic service lines remain strategically important because joint replacement, spine surgery, sports medicine and trauma can generate high procedural revenue, support specialist recruitment and strengthen referral capture. Large integrated delivery networks frequently negotiate enterprise contracts across multiple facilities, while physician-owned or joint-venture ASCs focus on implant standardization, predictable turnover and cost per case. Manufacturers therefore require different commercial models for tertiary hospitals, community systems and ambulatory centers.

From 2026 to 2035, the most important strategic transition will be from device-led selling to procedure-platform competition. Market leaders are connecting implants, robotics, navigation, imaging, disposable instrumentation, patient engagement and outcomes data into integrated ecosystems. This model increases customer switching costs and allows vendors to influence the full procedural pathway. However, specialized companies can still gain share when they solve a clear clinical or economic problem, such as enabling endoscopic decompression, simplifying sacroiliac fusion, improving anchor fixation, reducing fluoroscopy, or making robotic guidance practical for lower-volume facilities.

 

Key Market Drivers: What’s Fueling the U.S. Minimally Invasive Orthopedic Devices Market Boom?

The first major driver is the scale and persistence of musculoskeletal disease. Arthritis affects tens of millions of U.S. adults, and prevalence exceeds half of adults aged 75 and older. Osteoarthritis is a principal reason for hip and knee replacement, while degenerative disc disease, spinal stenosis, rotator cuff disease, meniscal injury and foot-and-ankle degeneration create additional procedural demand. The burden is amplified by adult obesity prevalence above 40%, which increases mechanical loading, accelerates joint degeneration and raises the complexity of perioperative care. Minimally invasive techniques are attractive because they can limit tissue disruption in patients who may already have elevated surgical risk.

A second driver is demographic aging. The U.S. population age 65 and older represented approximately 18% of the population in 2024 and is projected to account for roughly one in five Americans around 2030. Aging increases the incidence of osteoarthritis, osteoporosis, lumbar stenosis, degenerative scoliosis, rotator cuff pathology and fragility fractures. It also creates demand for less disruptive procedures that can restore mobility while reducing hospitalization and rehabilitation requirements. The aging trend supports both primary procedures and a growing revision market as earlier generations of implants reach the end of their service life.

A third driver is the migration of orthopedic procedures to outpatient settings. Total knee and total hip arthroplasty can be performed on an inpatient or outpatient basis when patient selection and clinical criteria are appropriate, and Medicare payment policy continues to formalize quality measurement for these procedures. The economic incentive is clear: lower-acuity patients can often be treated in hospital outpatient departments or ASCs with lower facility cost and more standardized pathways. This shift increases demand for compact equipment, efficient instrument sets, disposable accessories, low-profile implants, rapid sterilization cycles and technologies that reduce variability between surgeons and sites.

A fourth driver is the growth of orthopedic robotics, navigation and digital planning. Robotic assistance is expanding from total and partial knee procedures into hip revision, shoulder replacement and spine surgery. Hospitals initially purchased robotics as a differentiation tool, but procurement committees increasingly expect measurable improvements in implant positioning, workflow repeatability, training support and case throughput. New handheld robotic systems and modular navigation platforms are widening the addressable customer base beyond large tertiary centers. As installed systems increase, recurring revenue grows through compatible implants, disposables, service contracts and software upgrades.

A fifth driver is the clinical and commercial maturity of arthroscopy and sports medicine. Knee and shoulder arthroscopy remain core minimally invasive orthopedic procedures, supported by high volumes of meniscal repair, ACL reconstruction, rotator cuff repair, labral repair and cartilage procedures. The category benefits from recurring consumable use and frequent product iteration. Knotless anchors, all-suture anchors, self-punching systems, improved suture configurations, radiofrequency probes and integrated fluid management can reduce procedural steps and support reproducible fixation. Demand is also sustained by active adults who prioritize mobility, shorter recovery and return to sport or work.

A sixth driver is the expansion of minimally invasive spine surgery. Tubular decompression, endoscopic discectomy, lateral and oblique interbody fusion, minimally invasive transforaminal lumbar interbody fusion, percutaneous pedicle screw fixation and sacroiliac fusion are gaining acceptance across selected indications. These approaches can reduce muscle stripping, blood loss and hospitalization compared with traditional open exposure. The commercial opportunity extends beyond implants to navigation, robotics, intraoperative imaging, endoscopy, expandable cages, access systems, biologics and specialized instruments. High training requirements remain a constraint, but they also create defensible vendor relationships through education and procedural support.

A seventh driver is hospital pressure to improve orthopedic episode economics. Joint replacement and spine episodes are increasingly measured through patient-reported outcomes, readmissions, complications and post-acute utilization. The next generation of bundled-care models will place greater emphasis on longitudinal accountability. Manufacturers that can help health systems standardize implants, reduce tray count, shorten operative time and document recovery outcomes will be better positioned in value analysis. This favors vendors with evidence, data integration and strong field support rather than companies competing primarily on unit price.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. minimally invasive orthopedic devices market is focused on precision, reproducibility, tissue preservation and portability. The market is moving from isolated instruments toward connected procedural systems that combine preoperative planning, intraoperative guidance, implant execution and postoperative data. Manufacturers are designing technologies for both high-acuity hospitals and cost-sensitive ambulatory environments, creating a two-tier innovation pathway: premium multi-specialty platforms for integrated delivery networks and compact, workflow-light systems for ASCs and community facilities.

Orthopedic robotics is broadening in scope. Robotic-assisted knee replacement remains the largest installed-base application, but recent development has extended into shoulder arthroplasty, spine navigation, hip revision and handheld robotic power systems. The commercial significance is not limited to capital sales. Robotics creates implant pull-through, service revenue, software upgrades and long-term procedural loyalty. The strongest systems are those that integrate seamlessly with existing implant portfolios, minimize room footprint, support multiple procedure types and provide actionable intraoperative data without lengthening setup time.

Endoscopic and ultra-minimally invasive spine surgery is another high-growth innovation area. Full-endoscopic decompression and discectomy platforms use small working channels, high-definition visualization and specialized instruments to access pathology with limited tissue disruption. Navigation and robotics are improving the accuracy of percutaneous screw placement and reducing dependence on repeated fluoroscopy. Expandable interbody cages and streamlined access systems are designed to facilitate implantation through smaller corridors while restoring alignment. Adoption will depend on surgeon training, payer acceptance, coding clarity and evidence demonstrating durable outcomes.

Arthroscopy innovation is increasingly centered on procedural efficiency. Higher-resolution visualization, smaller cameras, integrated pump control, disposable scopes, improved shaver performance and advanced radiofrequency tissue management are reducing friction in sports medicine workflows. Soft-tissue fixation is also evolving through knotless constructs, all-suture anchors, broad compression designs and stronger tendon-to-bone repair configurations. In ASCs, manufacturers are emphasizing standardized packs, fewer instrument trays and predictable disposable cost, because room turnover and inventory simplicity are as important as device performance.

Patient-specific planning and data-enabled orthopedics are becoming a strategic layer across joint reconstruction. CT-based and imageless planning, optical tracking, patient-specific guides and intraoperative analytics help surgeons adapt implant position to individual anatomy. Connected recovery platforms can collect patient-reported outcomes, mobility data and engagement metrics after discharge. These tools are not always large standalone revenue categories, but they influence implant selection and strengthen enterprise contracts. Over time, the data generated by these platforms may support risk-sharing arrangements and procedure benchmarking.

Materials and implant design are also improving. Porous titanium, additive manufacturing, low-profile plates, expandable cages, improved bearing surfaces and smaller fixation constructs can support bone integration and reduce implant prominence. In trauma and extremities, percutaneous instrumentation and anatomic plates are enabling fixation through smaller incisions. In sports medicine, biologic augmentation delivery systems are being developed to complement mechanical repair. Regulatory success alone will not determine adoption; manufacturers must provide surgeon training, real-world evidence, supply reliability and reimbursement support.

 

Segmentation Insights

The U.S. Minimally Invasive Orthopedic Devices Market is segmented on the basis of product category, application, end user, technology type and region. These five segmentations capture the major commercial differences in procedure volume, capital intensity, recurring consumable demand, clinical complexity and purchasing behavior.

 

By Product Category

• Arthroscopy and sports medicine devices represent the largest recurring-consumable category. The segment includes arthroscopes, cameras, light sources, fluid management systems, shavers, burs, radiofrequency probes, cannulas, suture anchors, meniscal repair devices, ACL fixation systems, graft preparation tools and cartilage repair instruments. Knee and shoulder procedures dominate demand, while hip, elbow, wrist and ankle arthroscopy provide smaller but attractive niches. Growth is supported by high procedure frequency, continuous design innovation and ASC adoption. Vendors with integrated visualization, powered instruments and implant portfolios can bundle capital placement with high-margin disposables.
• Minimally invasive spine devices form one of the fastest-growing product categories. Products include percutaneous pedicle screw systems, expandable and static interbody cages, tubular retractors, endoscopic access systems, decompression instruments, lateral and oblique access platforms, sacroiliac fusion implants, navigation arrays and robotic-compatible instruments. Value growth is driven by premium implants and enabling technologies rather than procedure count alone. Hospitals favor systems that can serve both minimally invasive and open cases, while specialty spine centers often prioritize workflow speed, small footprints and surgeon-specific instrument configurations.
• Minimally invasive joint reconstruction devices include implants and enabling systems used in small-incision, muscle-sparing and robotic-assisted hip, knee and shoulder replacement. The category includes partial and total joint implants, specialized minimally invasive instruments, robotic arms, handheld robotic systems, navigation platforms, patient-specific guides and planning software. Knee procedures account for the largest share, but hip and shoulder applications are expanding. The segment is highly concentrated because implant companies use robotics and digital platforms to reinforce long-term implant contracts.
• Percutaneous trauma and extremity fixation devices include cannulated screws, intramedullary nails, low-profile plates, compression systems, external fixation components, small-bone implants and specialized targeting instruments. These products are used in fracture fixation, foot and ankle reconstruction, hand and wrist procedures and selected trauma cases where soft-tissue preservation is important. Growth is supported by aging-related fractures, sports injuries and the expansion of outpatient foot-and-ankle surgery. Product differentiation depends on implant geometry, instrumentation simplicity, inventory breadth and the ability to address complex anatomy with fewer surgical exposures.
• Soft-tissue repair, biologic delivery and ancillary devices include tendon and ligament fixation systems, graft delivery tools, bone graft delivery instruments, osteobiologic application systems, wound closure products and procedure-specific disposable kits. Although fragmented, this category is strategically important because it adds recurring revenue to core implant procedures. Products that simplify preparation, reduce steps or improve repair compression can gain rapid surgeon adoption. Commercial success often depends on surgeon education and bundling with arthroscopy, trauma or spine portfolios.

 

By Application

• Knee procedures represent the largest application segment. The market includes arthroscopic meniscal repair, ACL and PCL reconstruction, cartilage treatment, partial knee replacement, total knee replacement and selected fracture fixation. More than 700,000 total knee replacements are performed annually in the United States, and arthroscopic knee procedures add a large recurring base. Growth is moving toward robotic assistance, cementless fixation, patient-specific alignment strategies, minimally invasive instrumentation and same-day discharge pathways. Manufacturers that combine implants, robotics and digital recovery tools are well positioned.
• Shoulder procedures are among the strongest growth applications. Rotator cuff repair, instability repair, labral repair, biceps procedures and shoulder arthroplasty depend heavily on minimally invasive and small-incision techniques. The shoulder category is benefiting from improved anchor designs, knotless repair, advanced suture constructs and the introduction of robotic assistance for shoulder replacement. Growth is also supported by an aging but active population and rising diagnosis of rotator cuff disease. Surgeon preference remains influential because repair technique varies substantially by pathology and training.
• Spine applications include decompression, discectomy, interbody fusion, percutaneous fixation, sacroiliac fusion and selected motion-preservation procedures. Lumbar degenerative disease accounts for the largest value pool, while cervical and thoracolumbar procedures provide additional demand. The fastest growth is expected in endoscopic decompression, robotic and navigation-guided fixation, lateral access surgery and expandable implants. Adoption is strongest in high-volume spine centers, but compact navigation and simplified instrumentation are enabling broader community use.
• Hip procedures include hip arthroscopy, minimally invasive total hip arthroplasty, robotic-assisted hip replacement and hip preservation surgery. Hip arthroscopy addresses labral pathology and femoroacetabular impingement in selected patients, while small-incision and robotic approaches are increasingly used in total hip replacement. Growth is supported by aging demographics, active middle-aged patients and outpatient migration. The commercial mix includes implants, specialized reamers and broaches, navigation, robotic planning and disposable access instruments.
• Foot, ankle, hand, wrist and trauma applications collectively form a diversified growth segment. Minimally invasive bunion correction, percutaneous osteotomy, ankle arthroscopy, small-joint fusion, fracture fixation and sports-related extremity repair are increasingly performed in ambulatory settings. These procedures require low-profile implants, cannulated systems, compact power tools and imaging-compatible instruments. The segment is less concentrated than large-joint reconstruction, allowing specialized companies to compete through procedure-specific design and surgeon education.

 

By End User

• Hospitals and integrated health systems are the dominant end users by value. They account for most complex spine, trauma, revision joint and high-risk orthopedic procedures, as well as a large share of robotic capital purchases. Large systems negotiate enterprise implant contracts, standardize vendors and use value analysis committees to assess new technology. Decisions increasingly consider utilization guarantees, service coverage, instrument logistics, software integration and evidence on length of stay or complications. Vendors with broad portfolios can bundle robotics, implants, sports medicine and trauma products across multiple sites.
• Orthopedic specialty hospitals and academic medical centers are strategically important early adopters. These institutions perform high procedural volumes, manage complex referrals, participate in clinical research and train surgeons. They are more likely to evaluate emerging robotics, endoscopic spine techniques, novel implant materials and advanced soft-tissue repair. Their adoption can influence community practice through fellowship training, publications and surgeon referrals. Procurement is evidence-intensive, but premium technologies can gain access when they improve differentiation or expand procedural capability.
• Ambulatory surgery centers are the fastest-growing end-user segment. ASCs are increasingly performing arthroscopy, sports medicine, foot and ankle surgery, selected spine procedures and appropriately selected total joint replacements. Their economics favor rapid room turnover, limited tray count, predictable implant cost and minimal capital footprint. Compact navigation, handheld robotics, disposable scopes and standardized procedure packs are particularly well suited to this environment. Manufacturers must often support flexible contracting because many ASCs are physician-owned or operate through hospital-physician joint ventures.
• Community hospitals and regional orthopedic centers represent a broad middle market. These facilities may not support the highest-acuity revision or deformity cases, but they generate substantial volume in primary joint replacement, routine arthroscopy, trauma and degenerative spine care. They typically seek technologies that are clinically proven, easy to train and serviceable across multiple surgeons. Modular platforms and shared capital models can accelerate adoption by reducing the risk of underutilized equipment.
• Office-based orthopedic practices and outpatient specialty clinics are smaller end users for surgical devices but increasingly important in diagnostic, preoperative and postoperative pathways. They influence implant selection through physician preference and may use ultrasound-guided intervention, digital planning, bracing, remote monitoring and biologic delivery technologies. As care pathways become more connected, device companies will use these settings to support patient education, surgical preparation and recovery tracking.

 

By Technology Type

• Arthroscopic and endoscopic visualization technologies represent a foundational technology segment. High-definition and 4K cameras, smaller scopes, chip-on-tip systems, fluid management, light sources and disposable visualization devices improve access and image quality through small portals. In orthopedics, visualization is closely linked to powered instruments and soft-tissue repair. Growth will come from integrated towers, disposable or hybrid scopes, better smoke and fluid control, and compact systems designed for ASCs.
• Robotic-assisted and navigation-guided technologies are the fastest-growing technology type by value. Systems are used for knee, hip, shoulder and spine procedures and increasingly support multiple applications on a single platform. The market includes robotic arms, handheld robotic tools, optical navigation, 3D planning, intraoperative tracking and robotic-compatible instruments. Adoption depends on case volume, implant pull-through, surgeon engagement and capital financing. Portable and lower-cost systems are expected to expand penetration into community hospitals and ASCs.
• Percutaneous and small-incision implant delivery technologies include cannulated instruments, guidewire-based systems, tubular access, expandable implants, targeted fixation and minimally invasive insertion tools. These technologies are central to spine, trauma and extremity procedures. Their value proposition is strongest when they reduce tissue exposure without compromising fixation strength. Product development is focused on smaller profiles, simplified targeting, improved imaging visibility and compatibility with navigation.
• Powered, radiofrequency and soft-tissue management technologies include shavers, burs, saws, drills, ablation probes, tissue sealers and automated impaction tools. These systems are used across arthroscopy, joint replacement and trauma. Innovation is aimed at reducing surgeon fatigue, improving cutting control, minimizing thermal injury and integrating power settings with procedural planning. In high-volume settings, reliability and service response are critical purchasing factors because equipment downtime can disrupt multiple cases.
• Digital planning, patient-specific and connected orthopedic technologies form an emerging cross-market layer. This segment includes CT-based planning, imageless mapping, patient-specific guides, AI-assisted segmentation, recovery applications, patient-reported outcome collection and data dashboards. Although software revenue remains smaller than implant revenue, digital tools influence customer retention and procedure standardization. Their importance will rise as hospitals face mandatory outcome reporting and broader episode accountability.

 

Regional Insights: Where the Market Is Growing Fastest

The U.S. Minimally Invasive Orthopedic Devices Market is geographically segmented into the South, Northeast, West and Midwest. Regional performance varies according to population growth, age structure, obesity and arthritis burden, orthopedic surgeon density, ASC penetration, hospital consolidation, sports participation, trauma volume and adoption of robotics and digital surgery. The South represented the largest regional market in 2025, while the West is expected to record the fastest growth through 2035. The Northeast remains the highest-acuity and evidence-intensive market, and the Midwest provides a stable base of joint reconstruction, spine and sports medicine demand.

South

The South accounted for an estimated USD 5.20 billion in 2025 and is projected to reach approximately USD 11.62 billion by 2035, reflecting an above-market CAGR of about 8.37%. The region includes Alabama, Arkansas, Delaware, the District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia and West Virginia. Its leadership is supported by population scale, rapid migration into major metropolitan areas, a large older-adult population, high obesity and arthritis burden, expanding hospital systems and strong growth in ambulatory orthopedic capacity.

Texas and Florida are the two largest state markets in the region. Texas combines large urban medical hubs in Houston, Dallas-Fort Worth, Austin and San Antonio with extensive suburban growth and a broad network of orthopedic hospitals and ASCs. The state is attractive for robotic joint replacement, minimally invasive spine, sports medicine and trauma devices. Florida has one of the country’s largest populations of older adults and therefore generates substantial demand for hip, knee, shoulder and spine procedures. Same-day joint replacement and ambulatory orthopedic surgery are expanding in both states, supporting compact enabling technologies and standardized implant programs.

North Carolina, Georgia, Tennessee and Virginia are high-growth state markets because of population inflows, academic medical centers, regional referral systems and health-system capital investment. North Carolina has strong orthopedic and spine programs across the Research Triangle, Charlotte and the Triad. Georgia is anchored by Atlanta’s large provider networks and growing suburban demand. Tennessee benefits from major healthcare companies and established orthopedic centers, while Virginia combines affluent metropolitan markets with large integrated systems. Maryland and the District of Columbia add high-acuity academic and federal healthcare demand.

Alabama, Mississippi, Louisiana, Kentucky, West Virginia, Arkansas and Oklahoma have elevated musculoskeletal and obesity burden but uneven access to advanced orthopedic care. Large referral centers in these states can support premium spine, robotics and trauma systems, while rural areas require scalable solutions that reduce travel and recovery time. For manufacturers, the opportunity is twofold: sophisticated platforms in tertiary centers and cost-efficient minimally invasive systems for community hospitals and ambulatory facilities. Training, field support and instrument availability are especially important in markets with lower specialist density.

The South is expected to retain the largest regional share through 2035. Growth will be driven by total joint replacement, outpatient migration, minimally invasive spine adoption, sports medicine demand and continued construction of ambulatory facilities. Competitive success will depend on health-system contracting in large metropolitan areas and strong distributor or direct-sales coverage across geographically dispersed secondary markets.

West

The West represented an estimated USD 3.42 billion in 2025 and is projected to reach approximately USD 8.04 billion by 2035, the fastest regional CAGR at about 8.92%. The region includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington and Wyoming. Growth is supported by population expansion in Mountain West states, advanced academic centers, strong ASC adoption, digital health integration and early acceptance of robotics, navigation and endoscopic techniques.

California is the largest state market in the West and one of the most important orthopedic technology markets nationally. Its scale, academic medical centers, large commercially insured population and concentration of medtech innovation support early adoption of robotic joint reconstruction, endoscopic spine, advanced arthroscopy and connected recovery platforms. The state also has substantial sports medicine demand and high procedural diversity. However, purchasing is fragmented across large systems, independent physician groups and ambulatory networks, requiring flexible contracting and strong evidence of economic value.

Arizona, Nevada, Colorado and Utah are high-growth markets. Arizona and Nevada benefit from rapid population growth and aging demographics, supporting joint replacement and spine procedures. Colorado has a strong sports and active-lifestyle culture, creating demand for arthroscopy, ligament repair and cartilage technologies, while its integrated health systems are receptive to data-enabled care. Utah combines population growth, established orthopedic expertise and a favorable environment for outpatient surgery. These states are likely to adopt portable robotics and compact navigation systems faster than mature markets with constrained capital budgets.

Washington and Oregon are characterized by sophisticated health systems, rigorous technology assessment and strong adoption of outpatient care. Manufacturers must provide clinical evidence, interoperability and clear workflow benefits. Idaho, Montana, Wyoming, Alaska and New Mexico are smaller markets with dispersed populations, making regional referral centers and surgeon training critical. Minimally invasive approaches can be valuable in these states because shorter recovery and reduced hospitalization can lower the burden of travel for patients who live far from tertiary centers. Hawaii is a smaller but premium market shaped by island logistics and concentrated hospital purchasing.

The West will gain market share through 2035 as orthopedic care becomes more digital, ambulatory and technology-enabled. Growth will be strongest in robotic and navigation systems, sports medicine, outpatient joint replacement and minimally invasive spine. The region’s innovation ecosystem also makes it an important launch market for emerging companies seeking clinical champions and early commercial validation.

Northeast

The Northeast accounted for an estimated USD 3.56 billion in 2025 and is projected to reach approximately USD 7.50 billion by 2035, representing a CAGR of about 7.74%. The region includes Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island and Vermont. Its market strength is driven by dense academic medical networks, high specialist concentration, complex case mix, strong commercial insurance in major metropolitan areas and early adoption of evidence-backed technology.

New York is the largest state market in the Northeast. Large health systems in New York City, Long Island, Westchester and upstate metropolitan areas generate high volumes across joint reconstruction, spine, sports medicine and trauma. Procurement is increasingly centralized, which can create large contract opportunities but also significant price pressure. Massachusetts is disproportionately influential because of its academic hospitals, research base and surgeon training programs. New technology often gains clinical visibility in the state before broader national adoption.

Pennsylvania and New Jersey provide large procedural bases. Pennsylvania combines major academic centers in Philadelphia and Pittsburgh with extensive community hospital networks. New Jersey has a dense population, strong ambulatory surgery activity and high access to commercially insured patients. Connecticut and Rhode Island support premium orthopedic care through concentrated health systems, while New Hampshire, Maine and Vermont are smaller markets with aging populations and rural access challenges. In northern New England, technologies that support shorter stays and efficient referral pathways are particularly relevant.

The Northeast is expected to grow slightly below the national average because population growth is slower and the market is already mature. Nevertheless, it will remain one of the highest-value regions on a per-procedure basis. Complex revision surgery, academic adoption, clinical trials and premium enabling technologies support revenue. Manufacturers must meet demanding evidence standards and navigate sophisticated value analysis committees. Strong health-economic documentation and outcomes data are often necessary to displace established vendors.

Midwest

The Midwest represented an estimated USD 2.67 billion in 2025 and is projected to reach approximately USD 5.50 billion by 2035, a CAGR of about 7.49%. The region includes Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota and Wisconsin. Demand is supported by established orthopedic referral centers, high arthritis and obesity prevalence in several states, strong community hospital networks and a significant base of joint replacement and spine procedures.

Illinois, Ohio, Michigan and Minnesota are the largest state markets. Illinois benefits from Chicago’s academic and community provider ecosystem. Ohio has nationally recognized orthopedic and spine programs and broad regional referral capacity. Michigan supports large joint reconstruction and sports medicine volumes, while Minnesota is strategically important because of its medtech ecosystem and concentration of orthopedic expertise. These states are attractive for enterprise contracts that combine implants, robotics, navigation and service support.

Indiana, Wisconsin and Missouri provide stable demand through integrated health systems, orthopedic specialty groups and ambulatory centers. Iowa, Kansas and Nebraska have smaller populations but strong regional referral networks and meaningful joint replacement volumes. North Dakota and South Dakota are lower-volume markets where rural access and travel distances shape care delivery. Portable navigation, efficient implant sets and remote recovery tools can create value by supporting more care within regional centers and reducing dependence on distant tertiary hospitals.

The Midwest will remain a durable market for mature arthroscopy, trauma, spine and joint reconstruction devices. Growth will be less dependent on population expansion than in the South or West and more dependent on replacement cycles, outpatient migration and technology upgrades. Vendors can gain share through reliable service, clinical education, cost-effective contracting and relationships with integrated delivery networks. The region is particularly receptive to technologies that demonstrate practical workflow improvement rather than innovation for its own sake.

 

Key Market Players

The U.S. Minimally Invasive Orthopedic Devices Competitive Landscape is moderately consolidated in large-joint reconstruction, robotics, spine and arthroscopy, while remaining fragmented in extremities, endoscopic spine and specialized soft-tissue repair. Competition is increasingly platform-based. Large medtech companies use implant breadth, capital equipment, digital planning, service infrastructure and enterprise contracting to defend share. Specialized companies compete through focused procedure innovation, surgeon training and faster product iteration.

Some of the key players in the U.S. Minimally Invasive Orthopedic Devices industry are:

1. Stryker Corporation

2. Zimmer Biomet Holdings, Inc.

3. DePuy Synthes (Johnson & Johnson MedTech)

4. Smith+Nephew

5. Medtronic plc

6. Globus Medical, Inc.

7. Arthrex, Inc.

8. CONMED Corporation

9. Enovis Corporation

10. B. Braun / Aesculap, Inc.

11. KARL STORZ SE & Co. KG

12. Olympus Corporation

13. Richard Wolf GmbH

14. ZimVie Inc.

15. Orthofix Medical Inc.

16. Alphatec Holdings, Inc.

17. SI-BONE, Inc.

18. Highridge Medical

19. Integra LifeSciences Holdings Corporation

20. MicroPort Orthopedics Inc.

21. THINK Surgical, Inc.

22. Treace Medical Concepts, Inc.

23. Anika Therapeutics, Inc.

24. joimax GmbH

Stryker, Zimmer Biomet, DePuy Synthes, Smith+Nephew, Medtronic, Globus Medical and Arthrex hold leading positions across major categories because they combine strong surgeon relationships with broad implant and enabling-technology portfolios. Stryker and Zimmer Biomet are particularly influential in robotic joint reconstruction. DePuy Synthes combines joint, trauma and spine platforms with digital orthopedics. Smith+Nephew and Arthrex are major competitors in sports medicine and arthroscopy, while Medtronic and Globus Medical are central to minimally invasive spine, navigation and robotics. CONMED, KARL STORZ, Olympus and Richard Wolf compete in visualization and arthroscopic equipment.

Market share through 2035 will be shaped by regulatory clearances, clinical evidence, implant pull-through, capital financing, ASC suitability, service reliability and surgeon training. Companies that can reduce instrument burden, support multiple procedures on one platform and document improvements in workflow or outcomes will be best positioned to defend premium pricing. Smaller competitors can win in focused categories, but they must overcome contracting leverage and installed-base advantages held by diversified medtech companies.

 

Recent Developments

Recent developments show that orthopedic robotics is expanding beyond its original knee and hip focus. In 2024, Zimmer Biomet received U.S. clearance for the ROSA Shoulder System, establishing a robotic-assisted platform for anatomic and reverse shoulder replacement. The development is strategically important because shoulder arthroplasty requires precise component positioning and had not previously been served by a dedicated commercial robotic system. It also demonstrates how established implant companies are extending robotics into additional joints to increase platform utilization.

In 2024, DePuy Synthes expanded the VELYS ecosystem through U.S. clearance for unicompartmental knee arthroplasty and launched an active robotic-assisted spine platform. These developments broadened the company’s digital orthopedics strategy across joint reconstruction and spinal fusion. Stryker received clearance for the Mako Spine application in 2024 and moved into broader commercial activity during 2025, while also introducing new Mako capabilities for hip revision and multi-specialty workflows. The competitive direction is clear: leading companies are building cross-procedure enabling platforms rather than single-application robots.

In 2026, Stryker expanded the Mako portfolio with a handheld robotic power system for total knee replacement. Handheld robotics could materially expand market penetration because it offers a different capital footprint and workflow than a large robotic arm. This is relevant for community hospitals and ASCs that want robotic execution but may not have enough volume or space for a traditional platform. The launch also increases competitive pressure on vendors developing compact or imageless orthopedic navigation systems.

Minimally invasive spine innovation has continued through robotic navigation, endoscopic access and implant design. FDA clearances during 2024-2026 included new robotic navigation instruments and systems intended for open or percutaneous spinal procedures. These developments are increasing the number of compatible implant ecosystems and reducing the degree to which spine robotics is controlled by a small number of incumbent platforms. At the same time, endoscopic spine companies are investing in surgeon training and evidence generation to support broader reimbursement and community adoption.

Reimbursement and quality policy are also evolving. Medicare has adopted patient-reported outcome measurement for elective primary total hip and knee arthroplasty, reinforcing the need for health systems to track functional recovery rather than procedural completion alone. The proposed expansion of joint-replacement episode models toward broader mandatory participation from 2027 would further increase attention to post-acute cost, readmissions and patient outcomes. This environment favors devices and digital platforms that can support predictable recovery, standardized pathways and defensible episode economics.

 

Conclusion

The U.S. Minimally Invasive Orthopedic Devices Market Size & Share is positioned for sustained expansion from USD 14.85 billion in 2025 to USD 32.66 billion by 2035, supported by an 8.20% CAGR during the forecast period. The market’s long-term strength is grounded in aging demographics, arthritis and obesity burden, outpatient procedure migration, surgeon demand for tissue-preserving techniques and rapid investment in robotics, navigation and digital planning. Growth will be driven by both procedure volume and a favorable mix shift toward premium enabling technologies and recurring disposables.

The most attractive opportunities will emerge in robotic-assisted joint reconstruction, endoscopic and navigation-guided spine surgery, advanced sports medicine fixation, compact ASC-ready equipment, percutaneous trauma and extremity systems, and connected orthopedic care. Arthroscopy will remain the largest recurring-consumable base, while spine and robotics will contribute disproportionate value growth. Successful companies will combine clinical performance with workflow efficiency, instrument simplification, reimbursement support and measurable recovery outcomes.

Regional opportunity will be led by the South because of population scale, aging and health-system expansion, followed by the West’s innovation-driven growth, the Northeast’s high-acuity procedural base and the Midwest’s stable orthopedic infrastructure. Texas, Florida, California, New York, Pennsylvania, Illinois, Ohio, North Carolina, Georgia, Arizona, Massachusetts, Michigan, Tennessee, Virginia, Minnesota, Colorado, New Jersey, Washington and Indiana will remain especially important state markets. Smaller states will offer targeted opportunities where minimally invasive approaches reduce travel, hospitalization and post-acute burden.

For clients evaluating this market, the central strategic question is not whether minimally invasive orthopedics will expand, but which procedural platforms will become embedded in hospital and ASC workflows. Vendors that sell isolated products will face increasing pressure from companies offering integrated implants, enabling technology, service and data. The next decade will reward manufacturers that make procedures more reproducible, portable and economically defensible while preserving surgeon control and delivering outcomes that matter to patients, providers and payers.

 

TABLE OF CONTENT

1. U.S. Minimally Invasive Orthopedic Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Minimally Invasive Orthopedic Device Manufacturers
1.6.2. Implant, Component, Biomaterial and Contract Manufacturing Suppliers
1.6.3. Hospitals and Integrated Delivery Networks
1.6.4. Orthopedic Specialty Hospitals and Academic Medical Centers
1.6.5. Ambulatory Surgery Centers and Outpatient Orthopedic Facilities
1.6.6. Group Purchasing Organizations, Distributors and Specialty Dealers
1.6.7. Orthopedic Surgeons, Payers, Regulators and Clinical Decision-Makers

What this section provides: This section defines the market boundary, study scope, methodology, assumptions, and stakeholder ecosystem so clients understand how the U.S. minimally invasive orthopedic devices market is measured and validated.

2. U.S. Minimally Invasive Orthopedic Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas

What this section provides: This section gives decision-makers a concise view of market size, growth direction, major procedure-volume pockets, competitive intensity, and priority opportunity areas.

3. U.S. Minimally Invasive Orthopedic Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Arthritis, Degenerative Joint and Spine Disease Burden
3.1.2. Growth in Outpatient and Same-Day Orthopedic Procedures
3.1.3. Expansion of Arthroscopy and Sports Medicine Procedures
3.1.4. Adoption of Robotic-Assisted and Navigation-Guided Orthopedic Surgery
3.1.5. Growth in Endoscopic and Percutaneous Spine Procedures
3.1.6. Aging Population, Obesity and Mobility-Restoration Demand
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Robotics, Navigation and Visualization Systems
3.2.2. Implant Pricing Pressure and Value Analysis Scrutiny
3.2.3. Reimbursement Variability Across Procedures and Sites of Care
3.2.4. Product Recall, Implant Failure and Surgical Safety Risk
3.2.5. Surgeon Training and Learning-Curve Requirements
3.3. Opportunities and Their Impact Analysis
3.3.1. Robotic-Assisted Joint Reconstruction Expansion
3.3.2. Endoscopic Spine and Ultra-Minimally Invasive Decompression
3.3.3. ASC-Ready Compact and Disposable Device Platforms
3.3.4. Patient-Specific Planning, AI and Connected Orthopedic Workflows
3.3.5. Minimally Invasive Extremity, Trauma and Sports Medicine Procedures
3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital and ASC Capital Procurement Behavior Analysis

What this section provides: This section explains the clinical, commercial, reimbursement, and operational forces shaping demand, helping clients evaluate growth opportunities, adoption barriers, and execution risks.

4. U.S. Minimally Invasive Orthopedic Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Robotics, Navigation and Connected Orthopedics
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.8. CMS Reimbursement and Coverage Landscape
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Initiatives and Musculoskeletal Health Programs
4.11. Impact of Escalating Geopolitical Tensions
4.12. Hospital and ASC Value Analysis Committee Decision Framework

What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, pricing, supply chain, digital adoption, and hospital and ASC procurement dynamics.

5. U.S. Minimally Invasive Orthopedic Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Arthroscopy and Sports Medicine Devices
5.1.2.1. Arthroscopes, Cameras and Visualization Systems
5.1.2.2. Fluid Management Systems and Accessories
5.1.2.3. Shavers, Burs and Powered Arthroscopy Instruments
5.1.2.4. Radiofrequency and Soft-Tissue Ablation Devices
5.1.2.5. Suture Anchors and Soft-Tissue Fixation Systems
5.1.2.6. Meniscal, Ligament and Cartilage Repair Devices
5.1.3. Minimally Invasive Spine Devices
5.1.3.1. Percutaneous Pedicle Screw Systems
5.1.3.2. Interbody Cages and Expandable Implants
5.1.3.3. Tubular Retractors and Access Systems
5.1.3.4. Endoscopic Spine Systems and Instruments
5.1.3.5. Sacroiliac Fusion and Motion-Preservation Devices
5.1.3.6. Robotic and Navigation-Compatible Spine Instruments
5.1.4. Minimally Invasive Joint Reconstruction Devices
5.1.4.1. Knee Reconstruction Implants and Instruments
5.1.4.2. Hip Reconstruction Implants and Instruments
5.1.4.3. Shoulder Reconstruction Implants and Instruments
5.1.4.4. Robotic-Assisted Joint Replacement Systems
5.1.4.5. Navigation and Patient-Specific Instrumentation
5.1.5. Percutaneous Trauma and Extremity Fixation Devices
5.1.5.1. Cannulated Screws and Compression Systems
5.1.5.2. Intramedullary Nails and Targeting Systems
5.1.5.3. Low-Profile Plates and Percutaneous Fixation Systems
5.1.5.4. Foot and Ankle Fixation Devices
5.1.5.5. Hand and Wrist Fixation Devices
5.1.6. Soft-Tissue Repair, Biologic Delivery and Ancillary Devices
5.1.6.1. Tendon and Ligament Repair Systems
5.1.6.2. Graft Preparation and Delivery Devices
5.1.6.3. Bone Graft and Osteobiologic Delivery Systems
5.1.6.4. Wound Closure and Procedure-Specific Disposable Kits

What this section provides: This section identifies the product categories and subcategories expected to generate the highest revenue contribution, recurring consumable demand, and strongest growth through 2035.

6. U.S. Minimally Invasive Orthopedic Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Knee Procedures
6.1.2.1. Meniscal Repair and Cartilage Procedures
6.1.2.2. ACL and PCL Reconstruction
6.1.2.3. Partial Knee Arthroplasty
6.1.2.4. Total Knee Arthroplasty
6.1.2.5. Robotic and Navigation-Guided Knee Surgery
6.1.3. Shoulder Procedures
6.1.3.1. Rotator Cuff Repair
6.1.3.2. Labral and Instability Repair
6.1.3.3. Biceps Tenodesis and Tendon Procedures
6.1.3.4. Anatomic and Reverse Shoulder Arthroplasty
6.1.4. Spine Procedures
6.1.4.1. Endoscopic and Minimally Invasive Decompression
6.1.4.2. Discectomy and Interbody Fusion
6.1.4.3. Percutaneous Fixation
6.1.4.4. Sacroiliac Joint Fusion
6.1.4.5. Robotic and Navigation-Guided Spine Surgery
6.1.5. Hip Procedures
6.1.5.1. Hip Arthroscopy and Hip Preservation
6.1.5.2. Minimally Invasive Total Hip Arthroplasty
6.1.5.3. Robotic and Navigation-Guided Hip Replacement
6.1.5.4. Percutaneous Hip Fracture Fixation
6.1.6. Foot, Ankle, Hand, Wrist and Trauma Procedures
6.1.6.1. Minimally Invasive Foot and Ankle Reconstruction
6.1.6.2. Hand and Wrist Arthroscopy and Fixation
6.1.6.3. Percutaneous Fracture Fixation
6.1.6.4. Sports-Related Extremity Repair

What this section provides: This section helps clients understand demand by orthopedic procedure and anatomical application, highlighting areas with strong volume growth, outpatient suitability, reimbursement relevance, and technology adoption.

7. U.S. Minimally Invasive Orthopedic Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.2.1. Tertiary and Quaternary Care Hospitals
7.1.2.2. Integrated Delivery Networks
7.1.2.3. Hospital Outpatient Departments
7.1.3. Orthopedic Specialty Hospitals and Academic Medical Centers
7.1.3.1. Orthopedic Specialty Hospitals
7.1.3.2. Academic and Teaching Medical Centers
7.1.3.3. High-Volume Referral and Research Centers
7.1.4. Ambulatory Surgery Centers
7.1.4.1. Physician-Owned ASCs
7.1.4.2. Hospital–Physician Joint-Venture ASCs
7.1.4.3. Corporate and Multi-Site ASC Networks
7.1.5. Community Hospitals and Regional Orthopedic Centers
7.1.5.1. Community Acute-Care Hospitals
7.1.5.2. Regional Orthopedic and Spine Centers
7.1.5.3. Rural Referral Hospitals
7.1.6. Office-Based Orthopedic Practices and Outpatient Specialty Clinics
7.1.6.1. Orthopedic Group Practices
7.1.6.2. Sports Medicine Clinics
7.1.6.3. Spine and Pain Intervention Clinics

What this section provides: This section explains which care settings and customer groups are expected to drive capital purchasing, implant utilization, procedure migration, and recurring disposable demand.

8. U.S. Minimally Invasive Orthopedic Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Arthroscopic and Endoscopic Visualization Technologies
8.1.2.1. High-Definition and 4K Visualization Systems
8.1.2.2. Chip-on-Tip and Miniaturized Scopes
8.1.2.3. Disposable and Hybrid Endoscopic Systems
8.1.2.4. Integrated Fluid and Image Management Platforms
8.1.3. Robotic-Assisted and Navigation-Guided Technologies
8.1.3.1. Robotic Arm Systems
8.1.3.2. Handheld Robotic Systems
8.1.3.3. Optical and Electromagnetic Navigation
8.1.3.4. Intraoperative Tracking and 3D Guidance
8.1.4. Percutaneous and Small-Incision Implant Delivery Technologies
8.1.4.1. Guidewire and Cannulated Delivery Systems
8.1.4.2. Tubular and Endoscopic Access Systems
8.1.4.3. Expandable and Targeted Implant Delivery
8.1.4.4. Low-Profile Percutaneous Fixation Technologies
8.1.5. Powered, Radiofrequency and Soft-Tissue Management Technologies
8.1.5.1. Powered Shavers, Burs, Saws and Drills
8.1.5.2. Radiofrequency Ablation and Coblation Systems
8.1.5.3. Automated Impaction and Bone Preparation Systems
8.1.5.4. Soft-Tissue Resection and Sealing Technologies
8.1.6. Digital Planning, Patient-Specific and Connected Orthopedic Technologies
8.1.6.1. CT-Based and Imageless Surgical Planning
8.1.6.2. AI-Assisted Segmentation and Decision Support
8.1.6.3. Patient-Specific Guides and Custom Instruments
8.1.6.4. Remote Recovery, Patient-Reported Outcomes and Data Platforms

What this section provides: This section evaluates the enabling technologies reshaping minimally invasive orthopedic care, including visualization, robotics, navigation, percutaneous delivery, powered instrumentation, and digital workflows.

9. U.S. Minimally Invasive Orthopedic Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Capital Equipment Purchase
9.1.2.2. Implant and Disposable Contracting
9.1.2.3. Lease, Placement and Utilization-Based Agreements
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.3.1. Multi-Hospital Vendor Standardization
9.1.3.2. Bundled Implant and Enabling-Technology Agreements
9.1.3.3. Service, Software and Outcomes-Based Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.4.1. National GPO Agreements
9.1.4.2. Regional and Specialty GPO Agreements
9.1.4.3. Committed and Aggregated Purchasing Models
9.1.5. Distributor and Specialty Supplier Sales
9.1.5.1. Orthopedic Specialty Distributors
9.1.5.2. Independent Sales Agencies
9.1.5.3. Surgical Supply and Equipment Distributors
9.1.6. Ambulatory and Physician-Owned Facility Procurement
9.1.6.1. ASC Direct Procurement
9.1.6.2. Physician Preference and Consignment Models
9.1.6.3. Procedure-Pack and Per-Case Purchasing Models

What this section provides: This section explains how minimally invasive orthopedic devices are purchased in the U.S., including hospital contracting, IDN standardization, GPO influence, distributor coverage, and ASC-focused purchasing models.

10. U.S. Minimally Invasive Orthopedic Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Orthopedic Procedure Volume and Surgical Infrastructure Analysis
10.1.4. Regional Reimbursement, Site-of-Care and Procurement Dynamics

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Minimally Invasive Orthopedic Device Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Minimally Invasive Orthopedic Device Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Minimally Invasive Orthopedic Device Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. Delaware
10.4.23.1. Overview
10.4.23.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.24. West Virginia
10.4.24.1. Overview
10.4.24.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.24.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.24.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.24.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.24.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.25. District of Columbia
10.4.25.1. Overview
10.4.25.2. District of Columbia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.25.3. District of Columbia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.25.4. District of Columbia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.25.5. District of Columbia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.25.6. District of Columbia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Minimally Invasive Orthopedic Device Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify priority U.S. geographies, orthopedic procedure-volume hubs, outpatient adoption hotspots, capital-investment clusters, and state-level commercial opportunities.

11. U.S. Minimally Invasive Orthopedic Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Company Profiles
11.3.1. Stryker Corporation
11.3.2. Zimmer Biomet Holdings, Inc.
11.3.3. DePuy Synthes (Johnson & Johnson MedTech)
11.3.4. Smith+Nephew
11.3.5. Medtronic plc
11.3.6. Globus Medical, Inc.
11.3.7. Arthrex, Inc.
11.3.8. CONMED Corporation
11.3.9. Enovis Corporation
11.3.10. B. Braun / Aesculap, Inc.
11.3.11. KARL STORZ SE & Co. KG
11.3.12. Olympus Corporation
11.3.13. Richard Wolf GmbH
11.3.14. ZimVie Inc.
11.3.15. Orthofix Medical Inc.
11.3.16. Alphatec Holdings, Inc.
11.3.17. SI-BONE, Inc.
11.3.18. Highridge Medical
11.3.19. Integra LifeSciences Holdings Corporation
11.3.20. MicroPort Orthopedics Inc.
11.3.21. THINK Surgical, Inc.
11.3.22. Treace Medical Concepts, Inc.
11.3.23. Anika Therapeutics, Inc.
11.3.24. joimax GmbH

Note: Each company profile will include company overview, minimally invasive orthopedic device portfolio, U.S. market strategy, financial positioning, clinical pipeline, regulatory updates, partnerships, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market share visibility, portfolio positioning, innovation direction, and strategic intelligence on major minimally invasive orthopedic device companies.

12. U.S. Minimally Invasive Orthopedic Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Multi-Application Orthopedic Robotics and Handheld Robotic Systems
12.2.2. Endoscopic and Ultra-Minimally Invasive Spine Platforms
12.2.3. AI-Assisted Planning, Navigation and Intraoperative Decision Support
12.2.4. Patient-Specific Implants, Instruments and 3D-Enabled Workflows
12.2.5. Disposable Visualization and Connected Recovery Platforms
12.3. Emerging Business Trends
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix

What this section provides: This section prepares clients for future technology shifts, site-of-care changes, market structure evolution, investment opportunities, and potential adoption scenarios through 2035.

13. U.S. Minimally Invasive Orthopedic Devices Market: Strategic Recommendations

13.1. Recommendations for Device and Implant Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Ambulatory Surgery Centers
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for New Entrants and Startups
13.7. Go-to-Market Strategy Considerations
13.8. Product Positioning and Portfolio Expansion Guidance

What this section provides: This section converts market intelligence into actionable strategy for growth planning, product positioning, ASC expansion, channel development, investment decisions, and competitive differentiation.

14. U.S. Minimally Invasive Orthopedic Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s limitations, legal boundaries, data-use terms, and forecasting assumptions.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Minimally Invasive Orthopedic Devices Market: Market Definition and Scope
TABLE 3: U.S. Minimally Invasive Orthopedic Devices Market: Research Methodology Framework
TABLE 4: U.S. Minimally Invasive Orthopedic Devices Market: Key Assumptions
TABLE 5: U.S. Minimally Invasive Orthopedic Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Minimally Invasive Orthopedic Devices Market: Stakeholder Analysis
TABLE 7: U.S. Minimally Invasive Orthopedic Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Minimally Invasive Orthopedic Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Minimally Invasive Orthopedic Devices Market: Market Attractiveness Index
TABLE 10: U.S. Minimally Invasive Orthopedic Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Minimally Invasive Orthopedic Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Minimally Invasive Orthopedic Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Minimally Invasive Orthopedic Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Minimally Invasive Orthopedic Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Minimally Invasive Orthopedic Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Minimally Invasive Orthopedic Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Minimally Invasive Orthopedic Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Minimally Invasive Orthopedic Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Minimally Invasive Orthopedic Devices Market: Hospital and ASC Capital Procurement Behavior Matrix
TABLE 20: U.S. Minimally Invasive Orthopedic Devices Market: PESTEL Analysis
TABLE 21: U.S. Minimally Invasive Orthopedic Devices Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Minimally Invasive Orthopedic Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 23: U.S. Minimally Invasive Orthopedic Devices Market: Value Chain Analysis
TABLE 24: U.S. Minimally Invasive Orthopedic Devices Market: Supply Chain Analysis
TABLE 25: U.S. Minimally Invasive Orthopedic Devices Market: Robotics, Navigation and Connected Orthopedics Impact
TABLE 26: U.S. Minimally Invasive Orthopedic Devices Market: Application & Innovation Landscape
TABLE 27: U.S. Minimally Invasive Orthopedic Devices Market: FDA Regulatory Framework Analysis
TABLE 28: U.S. Minimally Invasive Orthopedic Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 29: U.S. Minimally Invasive Orthopedic Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 30: U.S. Minimally Invasive Orthopedic Devices Market: Government Initiatives and Musculoskeletal Health Programs
TABLE 31: U.S. Minimally Invasive Orthopedic Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 32: U.S. Minimally Invasive Orthopedic Devices Market: Hospital and ASC Value Analysis Committee Decision Framework
TABLE 33: U.S. Minimally Invasive Orthopedic Devices Market: Product Category Snapshot, 2025
TABLE 34: Segment Dashboard; Definition and Scope, by Product Category
TABLE 35: U.S. Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 36: U.S. Minimally Invasive Orthopedic Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 37: U.S. Minimally Invasive Orthopedic Devices Market: Arthroscopy and Sports Medicine Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: U.S. Minimally Invasive Orthopedic Devices Market: Minimally Invasive Spine Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Minimally Invasive Orthopedic Devices Market: Minimally Invasive Joint Reconstruction Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Minimally Invasive Orthopedic Devices Market: Percutaneous Trauma and Extremity Fixation Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Minimally Invasive Orthopedic Devices Market: Soft-Tissue Repair, Biologic Delivery and Ancillary Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Minimally Invasive Orthopedic Devices Market: Application Snapshot, 2025
TABLE 43: Segment Dashboard; Definition and Scope, by Application
TABLE 44: U.S. Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 45: U.S. Minimally Invasive Orthopedic Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 46: U.S. Minimally Invasive Orthopedic Devices Market: Knee Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Minimally Invasive Orthopedic Devices Market: Shoulder Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Minimally Invasive Orthopedic Devices Market: Spine Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Minimally Invasive Orthopedic Devices Market: Hip Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Minimally Invasive Orthopedic Devices Market: Foot, Ankle, Hand, Wrist and Trauma Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Minimally Invasive Orthopedic Devices Market: End User Snapshot, 2025
TABLE 52: Segment Dashboard; Definition and Scope, by End User
TABLE 53: U.S. Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 54: U.S. Minimally Invasive Orthopedic Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 55: U.S. Minimally Invasive Orthopedic Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Minimally Invasive Orthopedic Devices Market: Orthopedic Specialty Hospitals and Academic Medical Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Minimally Invasive Orthopedic Devices Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Minimally Invasive Orthopedic Devices Market: Community Hospitals and Regional Orthopedic Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Minimally Invasive Orthopedic Devices Market: Office-Based Orthopedic Practices and Outpatient Specialty Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Minimally Invasive Orthopedic Devices Market: Technology Type Snapshot, 2025
TABLE 61: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 62: U.S. Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 63: U.S. Minimally Invasive Orthopedic Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 64: U.S. Minimally Invasive Orthopedic Devices Market: Arthroscopic and Endoscopic Visualization Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Minimally Invasive Orthopedic Devices Market: Robotic-Assisted and Navigation-Guided Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Minimally Invasive Orthopedic Devices Market: Percutaneous and Small-Incision Implant Delivery Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Minimally Invasive Orthopedic Devices Market: Powered, Radiofrequency and Soft-Tissue Management Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Minimally Invasive Orthopedic Devices Market: Digital Planning, Patient-Specific and Connected Orthopedic Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Minimally Invasive Orthopedic Devices Market: Procurement Channel Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 71: U.S. Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 72: U.S. Minimally Invasive Orthopedic Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 73: U.S. Minimally Invasive Orthopedic Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Minimally Invasive Orthopedic Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Minimally Invasive Orthopedic Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Minimally Invasive Orthopedic Devices Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Minimally Invasive Orthopedic Devices Market: Ambulatory and Physician-Owned Facility Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Minimally Invasive Orthopedic Devices Market: Regional Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Region
TABLE 80: U.S. Minimally Invasive Orthopedic Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 81: U.S. Minimally Invasive Orthopedic Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 82: West Region U.S. Minimally Invasive Orthopedic Devices Market: Regional Overview and Trends
TABLE 83: West Region U.S. Minimally Invasive Orthopedic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 84: West Region U.S. Minimally Invasive Orthopedic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 85: West Region U.S. Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 86: West Region U.S. Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 88: West Region U.S. Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 89: West Region U.S. Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 90: California Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 91: California Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 92: California Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 93: California Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 94: California Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 95: Washington Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 96: Washington Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 97: Washington Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 98: Washington Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 99: Washington Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 100: Arizona Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 101: Arizona Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 102: Arizona Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 103: Arizona Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 104: Arizona Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 105: Colorado Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 106: Colorado Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 107: Colorado Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 108: Colorado Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 109: Colorado Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 110: Oregon Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 111: Oregon Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 112: Oregon Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 113: Oregon Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 114: Oregon Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 115: Utah Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 116: Utah Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 117: Utah Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 118: Utah Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 119: Utah Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 120: Nevada Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 121: Nevada Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 122: Nevada Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 123: Nevada Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 124: Nevada Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 125: New Mexico Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 126: New Mexico Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 127: New Mexico Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 128: New Mexico Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 129: New Mexico Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 130: Idaho Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 131: Idaho Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 132: Idaho Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 133: Idaho Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 134: Idaho Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 135: Montana Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 136: Montana Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 137: Montana Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 138: Montana Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 139: Montana Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 140: Wyoming Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 141: Wyoming Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 142: Wyoming Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 143: Wyoming Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 144: Wyoming Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 145: Alaska Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 146: Alaska Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 147: Alaska Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 148: Alaska Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 149: Alaska Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 150: Hawaii Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 151: Hawaii Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 152: Hawaii Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 153: Hawaii Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 154: Hawaii Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 155: Northeast Region U.S. Minimally Invasive Orthopedic Devices Market: Regional Overview and Trends
TABLE 156: Northeast Region U.S. Minimally Invasive Orthopedic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 157: Northeast Region U.S. Minimally Invasive Orthopedic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 158: Northeast Region U.S. Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 159: Northeast Region U.S. Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 160: Northeast Region U.S. Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 161: Northeast Region U.S. Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 162: Northeast Region U.S. Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 163: New York Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 164: New York Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 165: New York Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 166: New York Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 167: New York Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 168: Massachusetts Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 169: Massachusetts Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 170: Massachusetts Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 171: Massachusetts Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 172: Massachusetts Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 173: New Jersey Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 174: New Jersey Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 175: New Jersey Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 176: New Jersey Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 177: New Jersey Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 178: Pennsylvania Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 179: Pennsylvania Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 180: Pennsylvania Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 181: Pennsylvania Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 182: Pennsylvania Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 183: Connecticut Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 184: Connecticut Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 185: Connecticut Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 186: Connecticut Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 187: Connecticut Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 188: Maine Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 189: Maine Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 190: Maine Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 191: Maine Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 192: Maine Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 193: Vermont Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 194: Vermont Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 195: Vermont Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 196: Vermont Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 197: Vermont Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 198: New Hampshire Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 199: New Hampshire Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 200: New Hampshire Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 201: New Hampshire Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 202: New Hampshire Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 203: Rhode Island Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 204: Rhode Island Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 205: Rhode Island Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 206: Rhode Island Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 207: Rhode Island Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 208: South Region U.S. Minimally Invasive Orthopedic Devices Market: Regional Overview and Trends
TABLE 209: South Region U.S. Minimally Invasive Orthopedic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 210: South Region U.S. Minimally Invasive Orthopedic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 211: South Region U.S. Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 212: South Region U.S. Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 213: South Region U.S. Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 214: South Region U.S. Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 215: South Region U.S. Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 216: Texas Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 217: Texas Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 218: Texas Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 219: Texas Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 220: Texas Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 221: Florida Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 222: Florida Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 223: Florida Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 224: Florida Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 225: Florida Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 226: Georgia Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 227: Georgia Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 228: Georgia Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 229: Georgia Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 230: Georgia Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 231: North Carolina Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 232: North Carolina Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 233: North Carolina Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 234: North Carolina Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 235: North Carolina Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 236: Tennessee Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 237: Tennessee Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 238: Tennessee Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 239: Tennessee Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 240: Tennessee Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 241: South Carolina Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 242: South Carolina Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 243: South Carolina Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 244: South Carolina Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 245: South Carolina Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 246: Alabama Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 247: Alabama Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 248: Alabama Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 249: Alabama Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 250: Alabama Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 251: Mississippi Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 252: Mississippi Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 253: Mississippi Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 254: Mississippi Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 255: Mississippi Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 256: Louisiana Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 257: Louisiana Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 258: Louisiana Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 259: Louisiana Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 260: Louisiana Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 261: Arkansas Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 262: Arkansas Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 263: Arkansas Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 264: Arkansas Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 265: Arkansas Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 266: Kentucky Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 267: Kentucky Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 268: Kentucky Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 269: Kentucky Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 270: Kentucky Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 271: Oklahoma Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 272: Oklahoma Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 273: Oklahoma Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 274: Oklahoma Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 275: Oklahoma Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 276: Virginia Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 277: Virginia Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 278: Virginia Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 279: Virginia Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 280: Virginia Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 281: Maryland Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 282: Maryland Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 283: Maryland Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 284: Maryland Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 285: Maryland Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 286: Delaware Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 287: Delaware Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 288: Delaware Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 289: Delaware Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 290: Delaware Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 291: West Virginia Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 292: West Virginia Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 293: West Virginia Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 294: West Virginia Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 295: West Virginia Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 296: District of Columbia Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 297: District of Columbia Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 298: District of Columbia Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 299: District of Columbia Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 300: District of Columbia Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 301: Midwest Region U.S. Minimally Invasive Orthopedic Devices Market: Regional Overview and Trends
TABLE 302: Midwest Region U.S. Minimally Invasive Orthopedic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 303: Midwest Region U.S. Minimally Invasive Orthopedic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 304: Midwest Region U.S. Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 305: Midwest Region U.S. Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 306: Midwest Region U.S. Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 307: Midwest Region U.S. Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 308: Midwest Region U.S. Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 309: Illinois Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 310: Illinois Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 311: Illinois Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 312: Illinois Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 313: Illinois Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 314: Ohio Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 315: Ohio Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 316: Ohio Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 317: Ohio Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 318: Ohio Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 319: Michigan Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 320: Michigan Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 321: Michigan Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 322: Michigan Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 323: Michigan Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 324: Minnesota Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 325: Minnesota Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 326: Minnesota Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 327: Minnesota Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 328: Minnesota Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 329: Indiana Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 330: Indiana Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 331: Indiana Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 332: Indiana Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 333: Indiana Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 334: Wisconsin Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 335: Wisconsin Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 336: Wisconsin Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 337: Wisconsin Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 338: Wisconsin Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 339: Missouri Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 340: Missouri Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 341: Missouri Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 342: Missouri Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 343: Missouri Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 344: Iowa Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 345: Iowa Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 346: Iowa Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 347: Iowa Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 348: Iowa Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 349: Kansas Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 350: Kansas Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 351: Kansas Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 352: Kansas Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 353: Kansas Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 354: Nebraska Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 355: Nebraska Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 356: Nebraska Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 357: Nebraska Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 358: Nebraska Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 359: North Dakota Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 360: North Dakota Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 361: North Dakota Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 362: North Dakota Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 363: North Dakota Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 364: South Dakota Minimally Invasive Orthopedic Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 365: South Dakota Minimally Invasive Orthopedic Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 366: South Dakota Minimally Invasive Orthopedic Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 367: South Dakota Minimally Invasive Orthopedic Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 368: South Dakota Minimally Invasive Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 369: U.S. Minimally Invasive Orthopedic Devices Market: Competitive Landscape Snapshot, 2025
TABLE 370: U.S. Minimally Invasive Orthopedic Devices Market: Key Company Market Share Analysis, 2025
TABLE 371: U.S. Minimally Invasive Orthopedic Devices Market: Company Positioning Matrix
TABLE 372: U.S. Minimally Invasive Orthopedic Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 373: U.S. Minimally Invasive Orthopedic Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 374: Stryker Corporation: Company Profile
TABLE 375: Zimmer Biomet Holdings, Inc.: Company Profile
TABLE 376: DePuy Synthes (Johnson & Johnson MedTech): Company Profile
TABLE 377: Smith+Nephew: Company Profile
TABLE 378: Medtronic plc: Company Profile
TABLE 379: Globus Medical, Inc.: Company Profile
TABLE 380: Arthrex, Inc.: Company Profile
TABLE 381: CONMED Corporation: Company Profile
TABLE 382: Enovis Corporation: Company Profile
TABLE 383: B. Braun / Aesculap, Inc.: Company Profile
TABLE 384: KARL STORZ SE & Co. KG: Company Profile
TABLE 385: Olympus Corporation: Company Profile
TABLE 386: Richard Wolf GmbH: Company Profile
TABLE 387: ZimVie Inc.: Company Profile
TABLE 388: Orthofix Medical Inc.: Company Profile
TABLE 389: Alphatec Holdings, Inc.: Company Profile
TABLE 390: SI-BONE, Inc.: Company Profile
TABLE 391: Highridge Medical: Company Profile
TABLE 392: Integra LifeSciences Holdings Corporation: Company Profile
TABLE 393: MicroPort Orthopedics Inc.: Company Profile
TABLE 394: THINK Surgical, Inc.: Company Profile
TABLE 395: Treace Medical Concepts, Inc.: Company Profile
TABLE 396: Anika Therapeutics, Inc.: Company Profile
TABLE 397: joimax GmbH: Company Profile
TABLE 398: U.S. Minimally Invasive Orthopedic Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 399: U.S. Minimally Invasive Orthopedic Devices Market: Disruptive Technologies Impact Matrix
TABLE 400: U.S. Minimally Invasive Orthopedic Devices Market: Emerging Business Trends
TABLE 401: U.S. Minimally Invasive Orthopedic Devices Market: Business Opportunities for Startups and Existing Players
TABLE 402: U.S. Minimally Invasive Orthopedic Devices Market: Investment Prioritization Matrix
TABLE 403: U.S. Minimally Invasive Orthopedic Devices Market: Strategic Recommendations for Device and Implant Manufacturers
TABLE 404: U.S. Minimally Invasive Orthopedic Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 405: U.S. Minimally Invasive Orthopedic Devices Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 406: U.S. Minimally Invasive Orthopedic Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 407: U.S. Minimally Invasive Orthopedic Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 408: U.S. Minimally Invasive Orthopedic Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 409: U.S. Minimally Invasive Orthopedic Devices Market: Go-to-Market Strategy Considerations
TABLE 410: U.S. Minimally Invasive Orthopedic Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 411: U.S. Minimally Invasive Orthopedic Devices Market: Scope Limitation
TABLE 412: U.S. Minimally Invasive Orthopedic Devices Market: Data Use Limitation
TABLE 413: U.S. Minimally Invasive Orthopedic Devices Market: Forecasting Limitation
TABLE 414: U.S. Minimally Invasive Orthopedic Devices Market: Legal Disclaimer
TABLE 415: U.S. Minimally Invasive Orthopedic Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Minimally Invasive Orthopedic Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Hospital and ASC Capital Procurement Decision Framework
FIGURE 12: U.S. Minimally Invasive Orthopedic Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Minimally Invasive Orthopedic Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 15: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 16: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 17: Arthroscopy and Sports Medicine Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Minimally Invasive Spine Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Minimally Invasive Joint Reconstruction Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Percutaneous Trauma and Extremity Fixation Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Soft-Tissue Repair, Biologic Delivery and Ancillary Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 23: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Knee Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Shoulder Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Spine Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Hip Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Foot, Ankle, Hand, Wrist and Trauma Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 30: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Orthopedic Specialty Hospitals and Academic Medical Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Community Hospitals and Regional Orthopedic Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Office-Based Orthopedic Practices and Outpatient Specialty Clinics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 37: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Arthroscopic and Endoscopic Visualization Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Robotic-Assisted and Navigation-Guided Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Percutaneous and Small-Incision Implant Delivery Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Powered, Radiofrequency and Soft-Tissue Management Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Digital Planning, Patient-Specific and Connected Orthopedic Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 44: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Ambulatory and Physician-Owned Facility Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: West Region U.S. Minimally Invasive Orthopedic Devices Market Share and Leading Players, 2025
FIGURE 53: West Region Market Share Analysis by State, 2025
FIGURE 54: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: California Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Washington Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Arizona Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Colorado Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Oregon Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Utah Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Nevada Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: New Mexico Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Idaho Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Montana Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Wyoming Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Alaska Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Hawaii Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Northeast Region U.S. Minimally Invasive Orthopedic Devices Market Share and Leading Players, 2025
FIGURE 69: Northeast Region Market Share Analysis by State, 2025
FIGURE 70: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: New York Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Massachusetts Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: New Jersey Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Pennsylvania Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Connecticut Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Maine Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Vermont Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: New Hampshire Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Rhode Island Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: South Region U.S. Minimally Invasive Orthopedic Devices Market Share and Leading Players, 2025
FIGURE 81: South Region Market Share Analysis by State, 2025
FIGURE 82: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Texas Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Florida Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Georgia Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: North Carolina Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Tennessee Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: South Carolina Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Alabama Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Mississippi Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Louisiana Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Arkansas Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Kentucky Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Oklahoma Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Virginia Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Maryland Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Delaware Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: West Virginia Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: District of Columbia Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Midwest Region U.S. Minimally Invasive Orthopedic Devices Market Share and Leading Players, 2025
FIGURE 101: Midwest Region Market Share Analysis by State, 2025
FIGURE 102: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Illinois Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Ohio Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Michigan Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Minnesota Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Indiana Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Wisconsin Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Missouri Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Iowa Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Kansas Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Nebraska Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: North Dakota Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: South Dakota Minimally Invasive Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 116: Company Positioning Matrix
FIGURE 117: Key Player Product Portfolio Benchmarking
FIGURE 118: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 119: Minimally Invasive Orthopedic Device Innovation Roadmap
FIGURE 120: Robotic-Assisted Orthopedic Surgery Adoption Roadmap
FIGURE 121: Endoscopic and Minimally Invasive Spine Technology Opportunity Map
FIGURE 122: ASC and Same-Day Orthopedic Procedure Growth Roadmap
FIGURE 123: Future Market Scenario Analysis, 2026–2035
FIGURE 124: Disruptive Technologies Impact Matrix
FIGURE 125: Emerging Business Trends Matrix
FIGURE 126: Investment Prioritization Matrix
FIGURE 127: Strategic Growth Roadmap for U.S. Minimally Invasive Orthopedic Device Companies
FIGURE 128: Go-to-Market Strategy Framework
FIGURE 129: Product Positioning and Portfolio Expansion Framework
FIGURE 130: Report Scope and Disclaimer Framework